Crisaborole
Crisaborole inhengo yekirasi ye benzoxaboroles iyo 5-hydroxy-1,3-dihydro-2,1-benzoxaborole mune iyo phenolic.hydrogenyakatsiviwa neboka re4-cyanophenyl. A phosphodiesterase 4 inhibitor inoshandiswa kurapa zvinyoro kusvika pakati nepakati atopic dermatitis muvana nevakuru. Iine basa se phosphodiesterase IV inhibitor, anantipsoriaticuye isiri-steroidal anti-inflammatory drug. I benzoxaborole, ether inonhuhwirira uye nitrile.
Crisaborole inyayaoxaboroleyakabvumidzwa neFDA musi wa14 Zvita, 2016 seEucrisa, kurapwa kwepamusoro kune yakapfava kusvika pakati nepakati atopic dermatitis. Iyi isiri-steroidal agent inoshanda mukuvandudza kuoma kwechirwere, kuderedza njodzi yehutachiona uye kuderedza zviratidzo nezviratidzo muvarwere vane makore maviri nepamusoro. Iyo inoderedza kuputika kwepanzvimbo muganda uye inodzivirira kuwedzera kuwedzera kwechirwere nehupenyu hwakanaka hwekuchengetedza. Chimiro chayo chine aboronatomu, iyo inofambisa kupinda kweganda uye kusunga kune bimetal centre ye phosphodiesterase 4 enzyme. Parizvino iri pasi pekuvandudzwa senge topical kurapwa kwe psoriasis.
Crisaborole inonzi Phosphodiesterase 4 Inhibitor. Iyo nzira yekuita kwecrisaborole yakaita sePhosphodiesterase 4 Inhibitor.
Proposal18Quality Consistency Evaluation mapurojekiti akatenderwa4,uye6mapurojekiti ari pasi pekubvumidzwa.
Yepamberi yepasirese yemhando manejimendi system yakaisa hwaro hwakasimba hwekutengesa.
Kutariswa kwemhando yepamusoro kunomhanya kuburikidza nehupenyu hwese kutenderera kwechigadzirwa kuti ive nechokwadi chemhando uye yekurapa maitiro.
Professional Regulatory Affairs timu inotsigira zvinodiwa zvemhando panguva yekushandisa uye kunyoreswa.